Salesforce (CRM) Stock Analysis

BUY

CRM Equity Research — BUY — July 2026

Rating date

Jul 20, 2026

21 days ago

Desk view

BUY

5D move

Awaiting market data

Peer rank

75p

Investment card · CRM

Here is the analysis of CRM (Salesforce) as of July 20, 2026.

Desk rating

BUY

Tactical BUY · 12M BUY

Horizon

Short to medium term

Confidence

Medium

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

BUY

Catalysts

  • CRM's valuation story is the loudest signal this week. At ~12x forward earnings and ~$170, the stock is being framed as a deep-value software play, a characterization that would have been unthinkable during its high-growth years.
  • AI is both a tailwind and a headwind. The market seems uncertain whether CRM is an AI beneficiary (embedding AI into its platform) or a potential victim (AI reducing the need for its CRM suite).
  • Price action is telling a cautious near-term story. Underperformance vs. the broader market combined with institutional selling in Q2 suggests the value case has not yet found its catalyst.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

CRM Research Note

Full desk note for Jul 20, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

26 min read

WebserviceX · Agentic Research Desk

CRM Equity Research Note

Published Jul 20, 2026 · Desk view BUY · Generated 2026-07-21T15:36:27Z · Maintained by Walter Vijayakumar · Methodology · Track record

CRM Stock Rating Summary

CRM bias

BUY

Horizon

Short to medium term

CRM key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

CRM catalyst watch

CRM's valuation story is the loudest signal this week. At ~12x forward earnings and ~$170, the stock is being framed as a deep-value software play, a characterization that would have been unthinkable during its high-growth years.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Medium

How the call aged · 5D

Awaiting market dataPeer 75p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-07-21T15:52:20.837308+00:00.

5D move

2026-07-20 → awaiting

Outcome

Awaiting market data

5D trend

+1.50%

Vol (20D ann.)

+37.05%

vs SPY: +2.45%

Close 173.79 (USD, vendor closes)

Batch scorecard · 2026-07-20 · CRM

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace 262d5b6e

No QC issues recorded.